Indian equity markets are expected to open higher today, with GIFT Nifty futures at 90 points higher at 24,730 at 6:40 AM IST. This follows after benchmark indices saw huge drops in the last session, with Sensex plummeting 1,281.68 points (1.5%) to 81,148.22 and Nifty50 declining 346.35 points (1.39%) to 24,578.35. Market action today is likely to be driven by a combination of factors, such as the release of India and US April CPI data, India April WPI figures, continued fourth-quarter earnings announcements, news on the US-China trade deal, institutional action, and mixed global signals.
Across the globe, Asia-Pacific markets were largely higher today, following Wall Street's gains as US-China trade tensions eased. Nevertheless, Wall Street's major indexes closed in a mixed fashion, with the S&P 500 rising 0.72% and the Nasdaq Composite, which is weighted towards technology, rising 1.61%, while the Dow Jones fell 0.64%
Tata Motors is a stock to monitor. The company's consolidated net profit was ₹8,556 crore in Q4FY25, down by 51.2 percent from ₹17,528 crore in Q4FY24. Another source gave the consolidated net profit as ₹8,470 crore, down by 51% from the quarter ended March 2025. Tata Motors' total income was ₹121,012 crore in Q4FY25, an increase from ₹120,431 crore in Q4FY24
Bharti Airtel too is in the spotlight. The firm reported a net profit of ₹11,022 crore in Q4FY25, posting an impressive growth of 432 percent from ₹2,071.6 crore during the corresponding quarter of last year. Its revenue from operations increased 27 per cent year-on-year at ₹47,876.2 crore compared with ₹37,599.1 crore in Q4FY24. After accounting for exceptional items, the profit increased 77% year-on-year to ₹5,223 crore.
Hindustan Aeronautics Limited (HAL) is flagged as a stock to watch and should be in the limelight today as the company is due to report its fourth-quarter earnings
Cipla is one of the shares listed in focus today. The Managing Director and Global CEO of Cipla announced that the US government's instruction to pharmaceutical firms to cut prescription drug prices in 30 days will not impact Indian generic drug makers.
Tata Power will likely be in the limelight today as it will come out with its fourth-quarter earnings. Tata Power is also among the companies coming out with earnings today.
Jubilant Foodworks will likely be in the limelight today as it will be declaring earnings. It is also among the companies that are reporting earnings today.
Garden Reach Shipbuilders & Enginers (GRSE) a Defence PSU, had a notable 118.9% year-over-year rise in net profit to ₹244.2 crore in the fourth quarter. Its net profit rose 118.9 percent year-over-year to ₹244.2 crore, revenue rose 61.7 percent to ₹1,642 crore, and Ebitda doubled to ₹219 crore.
Bharti Hexacom registered a 79% quarter-on-quarter growth in net profit to ₹468 crore in the fourth quarter. It recorded a 110.4 percent year-on-year increase in net profit to ₹468.4 crore. The revenue went up by 22.5 percent year-on-year to ₹2,289 crore, which was a 2% increase on a quarter-on-quarter basis. Ebitda went up by 33 percent year-on-year to ₹1,167.8 crore.
Aditya Birla Capital posted a net profit of ₹885 crore in Q4FY25. This is a 30 per cent drop from last year's Q4 PAT of ₹1,271.34 crore. The company's Q4 revenue from operations, however, rose 13 per cent to ₹12,214.04 crore from ₹10,779.71 crore in Q4 last year. Another source posted a Q4 net profit of ₹654 crore with net interest income of ₹1,800 crore.
Metropolis Healthcare also reported a 19.4% decline in its Q4 net profit to ₹29 crore from ₹36 crore in Q4FY24. Its net profit for Q4 fell 19.4 per cent year-on-year at ₹29 crore, revenue went up 4.3 per cent at ₹345.3 crore, Ebitda declined 22 per cent at ₹62.3 crore, and margins contracted to 18 per cent.
GSK Pharma reported Q4 revenue of ₹966 crore, an increase of 6 per cent year-on-year, with profit at ₹260 crore. FY25 revenue was up 9 per cent to ₹3,723 crore, and profit increased by 32 per cent to ₹915 crore. A final dividend of ₹42 per share was recommended.
Tata Steel has set aside ₹15,000 crore to spend on capital expenditures across its Indian, UK, and Dutch operations for the current financial year.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.